TerrAscend Appoints Matthew J. Johnson as President, TerrAscend Corp. and TerrAscend USA

Published: November 29, 2018

TerrAscend Appoints Matthew J. Johnson as President, TerrAscend Corp. and TerrAscend USA

TerrAscend Corp., announced the appointment of Matthew J. Johnson as President, TerrAscend Corporation and TerrAscend USA, effective immediately. In this senior executive role, Mr. Johnson will be responsible for leading TerrAscend’s newly-formed U.S. operations. Michael Nashat will continue in his role as the Company’s Chief Executive Officer.

Mr. Johnson, a seasoned healthcare industry executive with over 25 years of experience, has held multiple senior-level positions with several large medical device and pharmaceutical companies including AbbVie, a company with $28 billion in 2017 revenue, which was spun-out of Abbott Laboratories in 2013. Most recently, he led the AbbVie Transition Office and was responsible for managing enterprise-wide transformation efforts, including merger integration. Prior to this, he headed Global Alliance Management within Abbott’s pharmaceuticals division where he drove collaboration strategy planning, alignment and communication among project teams for all of Abbott’s partnered pipeline products. Mr. Johnson’s Abbott expertise also includes merger, acquisition and licensing for Abbott’s global pharmaceuticals business, where he led new market initiatives and business development opportunities.

Additional senior level experience includes P&L management, operations in mature and emerging international markets, business development, marketing and finance, attained while serving in leadership roles with Brunswick Corporation and Baxter Healthcare Corporation. Mr. Johnson earned an MBA degree with honors from the Kellogg Graduate School of Management, Northwestern University, and a BA degree in Economics from the University of Vermont.

Jason Wild, Chairman of TerrAscend, stated, “Matt is a significant addition to the TerrAscend team as we execute and build a leading international cannabis company. His extensive experience successfully executing multi-billion dollar M&A transactions and leading their complex integrations is crucial as we expand into the U.S. cannabis market.”

Michael Nashat, Chief Executive Officer stated, “I am thrilled to have Matt, a senior-level pharmaceutical executive, join TerrAscend’s leadership team. We look forward to working with him as we implement our significant growth plans.”